RT @AlainClapaud: Les résultats d'IBM Watson dans la lutte contre le cancer remis en cause https://t.co/nVLs6eeGOc via @WSJ #IA
August 13, 2018
Big Blue spent billions on its Watson artificial intelligence product with a focus on cancer care. Sometimes, it didn't say more than doctors already knew. In other cases, Watson was tripped up by a lack of data in rare or recurring cancers and rapidly evolving treatments.